Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide

American Heart Journal

Volumn 143, Issue 1, 2002, Pages 176-180

  Wood, Mark A ^a   Gilligan, David M ^b   Brown Mahoney, Chris ^c   Nematzadeh, Fatemeh ^b   Stambler, Bruce S ^d   Ellenbogen, Kenneth A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; IBUTILIDE; IBUTILIDE FUMARATE; NIFEDIPINE;

ADULT; AGED; ARTICLE; CHANNEL GATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; QT INTERVAL; SODIUM CURRENT;

EID: 0036142675     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120156     Document Type: Article

References (16)

1. Ibutilide fumarate: A new agent for termination of atrial fibrillation and flutter
2. + current
3. Membrane activity of class III antiarrhythmic compounds: A comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide
4. + current through a nifedipine inhibited inward channel
5. Unique ionic mechanism of action of ibutilide on freshly isolated heart cells
6. Kr) in AT-1 cells
7. Kr, and effects on nuocardial refractoriness for class III antiarrhythmic agents
8. Ibutilide: Enhanced defibrillation via plateau sodium current activation
9. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia
10. Ibutilide: A new class III antiarrhythmic agent
11. A placebo-controlled trial of continuous intravenous diltiazem infusion ofr 24-hour heart rate control during atrial fibrillation and flutter: A mulicenter study
12. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
13. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose response study
14. Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease
15. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter
16. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and artial fibrillation